Biotechnology >>

Who's going to run Celgene when Hugin hangs it up? Fierce Biotech - 23-May-2014

The R&D rankings: Big Biotech once again makes Big Pharma look small Fierce Biotech - 23-May-2014

Sarepta bets on DMD drug approval with a $25M plant buy Fierce Biotech - 23-May-2014

Novartis, Boehringer vie for COPD market share with combo meds Fierce Biotech - 23-May-2014

Isis surges on promising head-to-head thrombosis drug study Fierce Biotech - 23-May-2014

Cell migration and the mysterious role of cadherin ScienceDaily - 23-May-2014

Blocking pain receptors extends lifespan, boosts metabolism in mice ScienceDaily - 23-May-2014

Computer models helping unravel the science of life? How cells of the fruit fly react to changes in the environment ScienceDaily - 23-May-2014

Safe alternatives to BPA: New technology may help identify ScienceDaily - 23-May-2014

Cells: RaDAR guides proteins into the nucleus ScienceDaily - 23-May-2014

HIV-positive children more likely to develop drug resistance ScienceDaily - 23-May-2014

Genes discovered linking circadian clock with eating schedule ScienceDaily - 23-May-2014

Pathology of Sanfilippo A syndrome: Research provides more insight ScienceDaily - 23-May-2014

Molecule acts as umpire to make tough life-or-death calls ScienceDaily - 23-May-2014

Cholesterol plays key role in cell migration, study shows ScienceDaily - 22-May-2014

Lipid transport: Research breakthrough paves way for understanding serious diseases ScienceDaily - 22-May-2014

Soil bacteria may provide clues to curbing antibiotic resistance ScienceDaily - 22-May-2014

Weak chemical forces combined to strengthen novel imaging technology ScienceDaily - 22-May-2014

Shire heads to the FDA with its dry eye drug despite a so-so PhIII Fierce Biotech - 22-May-2014

Wilex hands back some cancer drugs as it circles the biotech drain Fierce Biotech - 22-May-2014